Saluda Medical, Inc. (ASX:SLD)

Market Cap	365.43M
Revenue (ttm)	107.31M
Net Income (ttm)	-227.73M
Shares Out	252.02M
EPS (ttm)	-1.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,933
Average Volume	817,357
Open	1.450
Previous Close	1.435
Day's Range	1.420 - 1.450
52-Week Range	1.240 - 2.650
Beta	n/a
RSI	18.98
Earnings Date	n/a

About Saluda Medical

Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window. It also offers an application to sense, measure, and adjust the pulse. The company was founded in 2011 and is based in Bloomington, Minnesot...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 133
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SLD

Financial Performance

In 2025, Saluda Medical's revenue was $70.36 million, an increase of 36.13% compared to the previous year's $51.68 million. Losses were -$149.30 million, 52.6% more than in 2024.

Financial numbers in USD